Cargando…
DKK-1 Is Underexpressed in Mesenchymal Stem Cells from Patients with Ankylosing Spondylitis and Further Downregulated by IL-17
Dickkopf-1 (Dkk-1) is a key regulator of bone remodeling in spondyloarthropathies. Nevertheless, data regarding its expression in cells of pathophysiologic relevance, such as mesenchymal stem cells (MSCs), are lacking. Herein, we aimed to address DKK1 gene expression and Wnt pathway activation in MS...
Autores principales: | Daoussis, Dimitrios, Kanellou, Anastasia, Panagiotopoulos, Elias, Papachristou, Dionysios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224314/ https://www.ncbi.nlm.nih.gov/pubmed/35743102 http://dx.doi.org/10.3390/ijms23126660 |
Ejemplares similares
-
B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis
por: Daoussis, Dimitrios, et al.
Publicado: (2016) -
DNA methylation of DKK‐1 may correlate with pathological bone formation in ankylosing spondylitis
por: Zou, Yu‐Cong, et al.
Publicado: (2023) -
New insights into IL-17/IL-23 signaling in ankylosing spondylitis (Review)
por: Chisălău, Beatrice Andreea, et al.
Publicado: (2020) -
Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2022) -
Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis
por: Zhang, Li, et al.
Publicado: (2016)